Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$1.86M Buy
8,158
+17
+0.2% +$4.17K 0.18% 77
2022
Q4
$2.13M Buy
8,141
+27
+0.3% +$7.24K 0.21% 68
2022
Q3
$1.83M Buy
+8,114
New +$1.97M 0.2% 71
2022
Q2
Sell
-7,070
Closed -$1.71M 231
2022
Q1
$1.71M Buy
7,070
+188
+3% +$43.2K 0.16% 83
2021
Q4
$1.55M Buy
+6,882
New +$1.45M 0.15% 80

Other funds holding AMGN

HighTower Trust's AMGN Position: Q1 2023 in Review

HighTower Trust increased its Amgen (AMGN) stake by 0.21% in Q1 2023, buying an estimated $4.17K and bringing the position to 8,158 shares worth $1.86M. The position accounts for 0.18% of the portfolio, ranked #77.

HighTower Trust first reported a position in AMGN in Q4 2021 and has held it in 5 quarters since. The position peaked at $2.13M in Q4 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • HighTower Trust held 8,158 shares of Amgen worth $1.86M as of Q1 2023.
  • HighTower Trust bought 17 Amgen shares in Q1 2023, an estimated $4.17K.
  • Amgen made up 0.18% of HighTower Trust's portfolio in Q1 2023, its #77 holding.
  • HighTower Trust first reported a position in Amgen in Q4 2021 and has held it in 5 quarters since.
  • HighTower Trust's Amgen position peaked at $2.13M in Q4 2022.
  • 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.